Insider · CIK 0001849458

Tanguler Tolga

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001849458

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−106 sh	$319.03	−$33.8K	36,500
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−102 sh	$320.01	−$32.6K	36,398
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−215 sh	$320.81	−$69K	36,183
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−289 sh	$321.82	−$93K	35,894
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−350 sh	$323.01	−$113K	35,544
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−767 sh	$323.84	−$248K	34,777
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−272 sh	$324.88	−$88.4K	34,505
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−208 sh	$325.67	−$67.7K	34,297
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, Chief Commercial Officer	AAward	+4,769 sh	—	—	38,204
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−47 sh	$323.62	−$15.2K	38,157
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−90 sh	$324.65	−$29.2K	38,067
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−258 sh	$325.63	−$84K	37,809
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−392 sh	$326.81	−$128K	37,417
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−329 sh	$327.67	−$108K	37,088
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−100 sh	$328.71	−$32.9K	36,988
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−170 sh	$329.71	−$56.1K	36,818
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−81 sh	$330.85	−$26.8K	36,737
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−94 sh	$331.93	−$31.2K	36,643
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−37 sh	$332.64	−$12.3K	36,606
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	EVP, Chief Commercial Officer	AAward	+10.5K sh	—	—	10,480
2026-02-27	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+1,666 sh	—	—	33,435
2026-02-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−1,666 sh	—	—	0
2026-02-13	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−1,959 sh	$310.08	−$607K	31,769
2026-02-12	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, Chief Commercial Officer	AAward	+4,000 sh	—	—	33,728
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−39 sh	$353.95	−$13.8K	31,199
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−42 sh	$355.16	−$14.9K	31,157
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−41 sh	$356.09	−$14.6K	31,116
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−96 sh	$357.17	−$34.3K	31,020
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−123 sh	$358.18	−$44.1K	30,897
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−85 sh	$359.14	−$30.5K	30,812
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−155 sh	$360.22	−$55.8K	30,657
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−98 sh	$361.45	−$35.4K	30,559
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−73 sh	$362.38	−$26.5K	30,486
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−47 sh	$363.55	−$17.1K	30,439
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−199 sh	$364.83	−$72.6K	30,240
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−220 sh	$365.56	−$80.4K	30,020
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−50 sh	$366.41	−$18.3K	29,970
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−41 sh	$367.40	−$15.1K	29,929
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−92 sh	$368.62	−$33.9K	29,837
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−40 sh	$369.48	−$14.8K	29,797
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−19 sh	$370.87	−$7,046.53	29,778
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−2 sh	$372.46	−$744.92	29,776
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−14 sh	$374.44	−$5,242.16	29,762
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−19 sh	$375.65	−$7,137.35	29,743
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−15 sh	$377.82	−$5,667.3	29,728
2026-01-11	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, Chief Commercial Officer	AAward	+3,800 sh	—	—	31,238
2025-10-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−55 sh	$446.53	−$24.6K	28,788
2025-10-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−27 sh	$447.92	−$12.1K	28,761
2025-10-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Commercial Officer	SSale	−86 sh	$448.77	−$38.6K	28,675

Recent filings

Accepted (ET)
Jun 294
Tanguler Tolga0001849458-26-000001
SEC(opens sec.gov)
Mar 64
Tanguler Tolga0001735276-26-000060
SEC(opens sec.gov)
Mar 44
Tanguler Tolga0001735276-26-000050
SEC(opens sec.gov)

Companies

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010